Inwound ApS: Financial statements 2020
CVR: 39766612
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Inwound ApS (CVR 39766612) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -72,275 and a net result of DKK -508,153. Equity in the 2020 report amounted to DKK -1,093,719. The company had 2 employees in the financial year.
- Gross Profit
- DKK -72,275
- Profit/Loss
- DKK -508,153
- Equity
- DKK -1,093,719
- Total Assets
- DKK 2,011,914
- Employees
- 2
Official annual report
How creditworthy is Inwound ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 15, 2020, Lasse Blirup Snejbjerg has joined the board of directors of Inwound ApS.
Inwound ApS has published its interim report for the period August 1, 2018 – December 31, 2019.
About Inwound ApS
Inwound ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named VulCur MedTech ApS. The management consists of Lasse Blirup Snejbjerg. The board consists of Carl Morten Bilbo (chair), Bent von Eitzen, Christopher Bromley and Lasse Blirup Snejbjerg. The company's owners include WINDING ROADS ApS, Akk Biotek Holding ApS and K Fischer Hansen ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -4,096,380 and a net result of DKK -7,706,800 compared with DKK -1,025,932 the year before. Equity in the 2025 report amounted to DKK 5,862,914.